US Patent 6,139,859 (Lice/Mite “Suffocation Only” Barrier Treatment): Claim Scope and US Landscape
United States Patent 6,139,859 claims topical methods for killing lice and/or mites (including head lice on human scalp) using a substantially air-impermeable, water-soluble or water-dispersible, skin-compatible liquid/barrier composition that kills only by suffocation, optionally combined with nits-loosening enzymes and followed by removal/rinsing. The claim set is built around a tight mechanism constraint (“suffocation is the only mechanism”) paired with barrier/delivery property limits (air-impermeability, water solubility/dispersibility, and skin compatibility), plus dependent claim variations that narrow viscosities, contact times, formulation classes (gels/jellies with gums), and surface-active/thickening ingredients.
What is the core claim theme and how broadly does it read?
Independent claim 1 (general animal skin/lice-or-mites method)
Claim 1 recites a 3-step method:
- A. Apply a water-soluble or water-dispersible, substantially air-impermeable, skin-compatible liquid composition to skin and hair containing lice and/or mites; formulation can range free-flowing to viscous.
- B. Hold until killed by suffocation; critical limitation: “suffocation is the only mechanism by which the composition kills the lice and/or mites.”
- C. Remove the composition and dead lice/mites from skin/hair.
Scope drivers in claim 1
- Mechanism lock: “suffocation is the only mechanism” excludes formulations that kill via neurotoxic action, anti-metabolic pathways, corrosive activity, or insecticidal/acaricidal biocidal effects, even if the formulation also blocks air.
- Barrier requirement: “substantially air-impermeable” requires a delivery matrix that physically restricts air to the parasite.
- Vehicle solubility/dispersibility: “water-soluble or water-dispersible” and “liquid composition” (free-flowing to viscous) keep the claimed formulation within dispersible/soluble barrier carriers, not waxes/oils that do not disperse or wash out as claimed.
- Application context: covers animal skin broadly (not just scalp) and also covers mites (independent claim 1 covers lice and/or mites).
Independent claim 10 (human scalp head lice variant)
Claim 10 is a parallel method, limited to:
- A. apply to scalp and hair
- B. leave until lice killed by suffocation only
- C. remove composition and dead lice
Dependent claim 12 adds a specific time window: 4 to 24 hours. Independent claim 10 otherwise keeps the same air-impermeable + water-soluble/dispersible + skin-compatible + “only suffocation” structure.
Independent claim 13 (animal skin + enzyme loosener + removal of enzyme with loosened nits)
Claim 13 expands beyond the “pure suffocation” sequence by adding a staged enzyme loosening step, with a separate removal step:
- A. Apply a water-rinseable, substantially air impermeable barrier composition to skin/hair.
- B. Leave until killed by suffocation.
- C. Remove barrier and dead lice.
- D. Apply effective quantity of at least one enzyme that loosens nits.
- E. Remove the enzyme together with loosened nits.
Claim 13 therefore creates a two-part treatment system: physical suffocation killing plus chemical/enzymatic loosening of nits, separated in time.
How do dependent claims narrow the formulation and process?
Enzyme (nits loosening)
- Claim 2: Enzyme that loosens nits in the scope of claim 1.
- Claim 11: Enzyme that loosens lice nits in the scope of claim 10.
- Claims 13–14: In the broader method, enzyme is applied after dead lice/barrier removal, then removed with loosened nits.
Practical interpretation for design-around and enforcement
- Claims are not just “enzymes optionally present.” In the independent claim 13 pathway, the enzyme has a timing and removal structure (D then E), which can be used to distinguish multi-step products that keep enzyme in contact longer, do not remove enzyme with loosened nits, or use non-enzymatic nits agents.
Rinsing/removal
- Claim 3 and Claim 20: removal by rinsing with water (removal mechanics can matter when accused products use oil-based removal, combing without rinsing, or solvent removal).
Surface-active agents and soaps
- Claim 4: at least one skin-compatible surfactant/soap selected from:
- water-soluble anionic, cationic, nonionic, polar nonionic, amphoteric, zwitterionic, and soaps.
- Claim 15: similar surfactant list, applied to claim 13’s step A composition.
This expands formulation scope materially: accused barrier carriers often use surfactant mixtures for spreading and film formation. The claim is broad across surfactant charge types.
Thickening
- Claim 5 and Claim 16: thickening agent included when the surfactant limitation is present (claim 5 depends on claim 4; claim 16 depends on claim 13 with thickening when in step A).
- Claim 6 and Claim 17: viscosity ≥ 1 centipoise at 20°C.
- Claim 7 and Claim 18: water-based pharmaceutically acceptable jelly containing a gum for step A.
Contact time
- Claim 8: left 4 to 24 hours (dependent on claim 1).
- Claim 9: specific 6 to 10 hours (dependent on claim 8).
- Claim 12: left 4 to 24 hours for the human scalp variant.
The time-window dependent claims are valuable in infringement and licensing: they can narrow enforcement to “leave-on durations” that match label-like use instructions.
What is likely the patent “center of gravity” for infringement?
Most enforceable pivot
The strongest single element across claims 1 and 10 is the combined:
- substantially air-impermeable barrier
- water-soluble or water-dispersible liquid
- killing by suffocation only (“only mechanism” constraint)
A product that kills lice by a dual mechanism (e.g., physical suffocation plus neurotoxic or acaricidal actives) can fall outside the “only mechanism” limitation, even if it also forms a film.
Most formulation-flexible areas
- Surfactant type (claim 4, 15): broad list.
- Viscosity threshold (claim 6, 17): low bar at ≥ 1 cP at 20°C.
- Free-flowing to viscous in claim 1: supports a wide viscosity spread above the threshold, with dependent claims carving out “at least 1 cP.”
Most process-sensitive area
- Contact time windows (claims 8, 9, 12).
- Enzyme timing and removal with loosened nits (claim 13 step D and E).
Claim-by-claim scope matrix (what must be present)
| Claim |
Target |
Step A formulation/property |
Killing mechanism |
Optional add-on |
Step B time |
Step C/D/E removal detail |
| 1 |
lice and/or mites on animal skin |
water-soluble or water-dispersible; substantially air-impermeable; skin-compatible; liquid (free-flowing to viscous) |
suffocation only |
none in claim 1 |
not limited in independent claim |
remove composition + dead lice/mites |
| 2 |
claim 1 |
same as claim 1 |
suffocation only |
enzyme that loosens nits |
none stated |
none stated |
| 3 |
claim 1 |
same as claim 1 |
suffocation only |
none added |
none stated |
rinsing with water |
| 4 |
claim 1 |
add surfactant/soap class |
suffocation only |
surfactant/soap |
none stated |
none stated |
| 5 |
claim 4 |
claim 4 + thickening agent |
suffocation only |
thickener |
none stated |
none stated |
| 6 |
claim 1 |
claim 1 + viscosity ≥ 1 cP at 20°C |
suffocation only |
none |
none stated |
none stated |
| 7 |
claim 1 |
water-based pharmaceutically acceptable jelly with a gum |
suffocation only |
none |
none stated |
none stated |
| 8 |
claim 1 |
same as claim 1 |
suffocation only |
none |
4 to 24 hours |
none stated |
| 9 |
claim 8 |
same as claim 1 |
suffocation only |
none |
6 to 10 hours |
none stated |
| 10 |
human scalp head lice |
water-soluble or water-dispersible; substantially air-impermeable; skin-compatible; liquid |
suffocation only |
none in claim 10 |
none stated |
remove composition + dead lice |
| 11 |
claim 10 |
same as claim 10 |
suffocation only |
enzyme loosens lice nits |
none stated |
none stated |
| 12 |
claim 10 |
same as claim 10 |
suffocation only |
none |
4 to 24 hours |
none stated |
| 13 |
lice and/or mites on animal skin (two-stage) |
step A: water-rinseable; substantially air impermeable barrier |
suffocation killing in B |
enzyme loosening nits added in D |
none stated |
C: remove barrier + dead lice; E: remove enzyme with loosened nits |
| 14 |
claim 13 |
claim 13 + human scalp; head lice |
suffocation killing |
enzyme loosening nits |
none stated |
enzyme removed with loosened nits |
| 15 |
claim 13 |
step A + surfactant/soap list |
suffocation killing |
enzyme loosening nits |
none stated |
enzyme removal in E |
| 16 |
claim 13 |
step A + thickening agent |
suffocation killing |
enzyme loosening nits |
none stated |
enzyme removal in E |
| 17 |
claim 13 |
step A + viscosity ≥ 1 cP at 20°C |
suffocation killing |
enzyme loosening nits |
none stated |
enzyme removal in E |
| 18 |
claim 13 |
step A + water-based jelly with gum |
suffocation killing |
enzyme loosening nits |
none stated |
enzyme removal in E |
| 19 |
claim 13 |
same as claim 13 |
suffocation killing |
none |
4 to 24 hours (step B) |
none stated |
| 20 |
claim 13 |
same as claim 13 |
suffocation killing |
none |
none stated |
rinsing with water (step C) |
Patent landscape implications in the US
Landscape characterization (based on claim structure)
The patent is positioned in the physical suffocation barrier segment of head lice/lice treatments, with a mechanism constraint meant to differentiate from conventional pharmacologic pediculicides. Its breadth comes from:
- general “lice and/or mites” on skin/hair,
- “water-soluble or water-dispersible” carrier,
- broad surfactant classes,
- low viscosity floor, and
- broad contact-duration window in dependent claims.
It is narrowed by the “suffocation is the only mechanism” requirement and the specific enzyme sequence in claim 13.
What types of competitor products are most likely to test the boundary
- Dimethicone-style silicones and other non-aqueous barrier films: these may fall outside “water-soluble or water-dispersible” and may also be removed differently than water rinsing, but they often emphasize suffocation. Their fit turns on whether they are water-dispersible/soluble and how they are removed.
- Conventional pediculicides (neuroactive actives): these are likely outside because killing is not “by suffocation only.”
- Combination products that mix barrier formation with actives: these risk non-infringement due to the “only mechanism” limitation unless the active is inert for killing.
- Products with enzymatic nit loosening: if they add enzymes but do not maintain the suffocation-only barrier killing, or if the enzyme is not used/timed/removed per claim 13, infringement depends on claim mapping.
How licensing/invalidation arguments typically map to these claims
- “Substantially air-impermeable” is usually litigated on film-forming properties and measured air permeability.
- “Water-soluble or water-dispersible” is testable via solubility/dispersibility outcomes in water and wash behavior.
- “Suffocation is the only mechanism” drives mechanistic evidence issues: whether any active ingredient (including surfactant or enzyme) contributes to lethality beyond suffocation.
Enzyme integration as a second lane
Claim 13 is a structural way to include enzymes without collapsing the suffocation-only limitation on killing. The “enzyme loosens nits” function is separated from the suffocation kill step. Products that combine enzyme and barrier simultaneously, or that use enzymes that also act on adult lice, create risk for either infringement or non-infringement depending on claim construction.
Key Takeaways
- US 6,139,859 claims topical lice/mites treatment using a substantially air-impermeable, water-soluble or water-dispersible, skin-compatible liquid that kills by suffocation only.
- Dependent claim scope broadens formulation (surfactant types, thickening, jelly-with-gum, viscosity ≥ 1 cP), while narrowing process parameters (leave-on 4-24 hours and specifically 6-10 hours).
- Independent claim 13 adds a two-stage enzyme nit-loosening workflow: apply enzyme after barrier removal and remove enzyme with loosened nits.
- The patent’s enforceability hinges on three elements: air impermeability, water solubility/dispersibility and removal by rinsing where claimed, and mechanism exclusivity (“suffocation only”).
FAQs
1) Does the patent cover lice on the human scalp?
Yes. Claim 10 is explicitly for “topical treatment of the human scalp infected with head lice,” using the suffocation-only barrier method.
2) Are enzymes required to be present?
No. Enzymes are optional depending on the claim path. They appear in claims 2, 11, and are integrated into the staged method in claim 13 (and downstream dependent claims).
3) What makes this patent different from neurotoxic pediculicides?
The method requires that in step B the lice/mites are killed by suffocation and suffocation is the only mechanism. That excludes killing via pharmacologic insecticidal pathways.
4) What time windows are claimed?
Dependent claims cover 4 to 24 hours (claims 8, 12, 19) and a narrower 6 to 10 hours window (claim 9).
5) Can surfactants be included?
Yes. Claims 4 and 15 allow a broad range of skin-compatible surfactants/soaps by charge class (anionic, cationic, nonionic, polar nonionic, amphoteric, zwitterionic, and soaps).
References
[1] United States Patent 6,139,859, “Method for topical treatment of lice and/or mites,” claims as provided by user.
